Pricing changes on Transact and Nucleus have come into effect today.

For Transact, the platform charge has been reduced from 0.27% to 0.26% for assets up to £600,000. Portfolios of less than £100k are charged at the same 0.26% for assets between £60k and £100k.

This pricing change was first announced in February, and follows the changes to buy commission earlier this year.

Transact is one of the rare adviser platforms that charges a buy commission of 0.05% for lower balances, but this is refunded above a value threshold. That threshold was lowered in March from £300k to £200k.

For Nucleus, the platform charge has gone from 0.35% to 0.33% for assets up to £500k. Nucleus has pledged that this marks the "first of what will be a series of reductions" across both the Nucleus and James Hay platforms.

Nucleus has also announced it will take a different approach to cash held on both platforms, adopting an "actively managed" approach which will see the platforms working to secure the best interest rates for clients while still retaining a margin on interest.

Both pricing changes on Transact and Nucleus have been reflected on Analyser.

If you have any custom or special pricing deals set up, it's worth checking in Analyser to see how these changes stack up, and if there's any impact for your clients.